The Adaptor Protein Sh2d3c Is Critical for Marginal Zone B Cell Development and Function

被引:11
作者
Al-Shami, Amin [1 ]
Wilkins, Carrie [1 ]
Crisostomo, Jeannette [1 ]
Seshasayee, Dhaya [2 ]
Martin, Flavius [2 ]
Xu, Nianhua [1 ]
Suwanichkul, Adisak [1 ]
Anderson, Stephen J. [1 ]
Oravecz, Tamas [1 ]
机构
[1] Lexicon Pharmaceut, The Woodlands, TX 77381 USA
[2] Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA
关键词
BONE-MARROW; ACTIVATION; CAS; TRAFFICKING; LYMPHOCYTES; MIGRATION; CHEMOKINE; INTEGRIN; SHEP1; CHAT;
D O I
10.4049/jimmunol.1000096
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Sh2d3c is an adaptor protein that has been implicated in T cell activation and shown to associate with different components of the integrin signaling pathway ex vivo. However, the in vivo significance of Sh2d3c expression in the regulation of the immune response and/or hematopoietic cell lineage development is not known. In this study, we show that expression of Sh2d3c is more critical for development and function of marginal zone B (MZB) cells than for T cell maturation. Mice deficient in Sh2d3c expression (Sh2d3c(-/-)) had a reduced number of MZB cells, and the residual MZB cells failed to properly capture polysaccharide Ags. Activation-induced proliferation, cytokine production, and migration of Sh2d3c(-/-) splenic B cells were also significantly reduced in vitro compared with wild-type (Sh2d3c(+/+)) cells. In contrast, T cell development and function were largely normal in Sh2d3c(-/-) mice. The thymi of Sh2d3c(-/-) mice showed no maturational abnormalities, the number of splenic T cells was only modestly reduced, and the T cells responded normally to in vitro polyclonal activation. The observed B cell deficiency in the Sh2d3c(-/-) mice led to diminished humoral immune response against thymus-independent type 2, but not thymus-dependent Ags, which highlights the primary in vivo role of Sh2d3c in regulating B cell development and function. The Journal of Immunology, 2010, 185: 327-334.
引用
收藏
页码:327 / 334
页数:8
相关论文
共 45 条
[1]   A role for thymic stromal lymphopoietin in CD4+ T cell development [J].
Al-Shami, A ;
Spolski, R ;
Kelly, J ;
Fry, T ;
Schwartzberg, PL ;
Pandey, A ;
Mackall, CL ;
Leonard, WJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 200 (02) :159-168
[2]   Alternative routes to maturity: branch points and pathways for generating follicular and marginal zone B cells [J].
Allman, D ;
Srivastava, B ;
Lindsley, RC .
IMMUNOLOGICAL REVIEWS, 2004, 197 :147-160
[3]   Ablation of ribosomal protein L22 selectively impairs αβ T cell development by activation of a p53-dependent checkpoint [J].
Anderson, Stephen J. ;
Lauritsen, Jens Peter Hoist ;
Hartman, Matthew G. ;
Foushee, Ann Marie DiGeorge ;
Lefebvre, Juliette M. ;
Shinton, Susan A. ;
Gerhardt, Brenda ;
Hardy, Richard R. ;
Oravecz, Tamas ;
Wiest, David L. .
IMMUNITY, 2007, 26 (06) :759-772
[4]   A chemokine-driven positive feedback loop organizes lymphoid follicles [J].
Ansel, KM ;
Ngo, VN ;
Hyman, PL ;
Luther, SA ;
Förster, R ;
Sedgwick, JD ;
Browning, JL ;
Lipp, M ;
Cyster, JG .
NATURE, 2000, 406 (6793) :309-314
[5]  
Beltrandelrio H., 2003, Model Organisms in Drug Discovery, P251
[6]   A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1) [J].
Bleul, CC ;
Fuhlbrigge, RC ;
Casasnovas, JM ;
Aiuti, A ;
Springer, TA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (03) :1101-1109
[7]   The follicular versus marginal zone B lymphocyte cell fate decision is regulated by Aiolos, Btk, and CD21 [J].
Cariappa, A ;
Tang, M ;
Parng, C ;
Nebelitskiy, E ;
Carroll, M ;
Georgopoulos, K ;
Pillai, S .
IMMUNITY, 2001, 14 (05) :603-615
[8]   B cells on the front line [J].
Cyster, JG .
NATURE IMMUNOLOGY, 2000, 1 (01) :9-10
[9]   Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs [J].
Cyster, JG .
ANNUAL REVIEW OF IMMUNOLOGY, 2005, 23 :127-159
[10]   SHEP1 function in cell migration is impaired by a single amino acid mutation that disrupts association with the scaffolding protein Cas but not with Ras GTPases [J].
Dail, M ;
Kalo, MS ;
Seddon, JA ;
Côté, JF ;
Vuori, K ;
Pasquale, EB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (40) :41892-41902